T cell activating Natural Killer cells (TaNK) as “off-the-shelf” biotherapeutic for HER2-positive solid tumors

Help

Back »

Details of project

Identifier

143771

Type

Principal investigator

Vereb, György

Title in Hungarian

T-sejteket aktiváló természetes ölősejtek (TaNK) HER2-pozitív szolid tumorok "off-the-shelf" biológiai terápiájára

Title in English

T cell activating Natural Killer cells (TaNK) as “off-the-shelf” biotherapeutic for HER2-positive solid tumors

Keywords in Hungarian

kiméra antigén receptor (CAR), NK sejt, bispecifikus T-sejt kapcsoló (BiTE), HER2, génszerkesztett immunsejt, célzott daganat immunterápia, élő gyógyszer

Keywords in English

chimeric antigen receptor (CAR), NK cell, bispecific T-cell engager (BiTE), HER2, gene-edited immune cell, targeted tumour immunotherapy, living drug

Discipline

Immunology (Council of Medical and Biological Sciences)

100 %

Panel

Immunity, Cancer and Microbiology

Department or equivalent

Department of Biophysics and Cell Biology (University of Debrecen)

Participants

Csaplár, Marianna
Gergely, Bence
Nagy, Lőrinc
Rebenku, István
Szöőr, Árpád
Ujlaky-Nagy, László

Starting date

2022-12-01

Closing date

2026-11-30

Funding (in million HUF)

48.000

FTE (full time equivalent)

8.00

state

running project

Back »